December 1, 2023
Last week, Robert Szulkin, Research Principal, Real World Evidence, discussed the need for real-world evidence studies,...
Read article
November 3, 2023
Written by Fei Tang and Evie Merinopoulou Reinforcement Learning (RL), a crucial component of machine learning (ML),...
Read article
October 25, 2023
The European Union (EU) health technology assessment (HTA) regulation aims to improve the availability of innovative...
Read article
October 20, 2023
Written by Grammati Sarri and Yannis Jemiai The spotlight for this year’s World Evidence-Based Healthcare Day (EBHC)...
Read article
October 2, 2023
Patients’ adherence to the medications or treatment regimens prescribed to them by their clinicians is an important...
Read article
September 8, 2023
Single-arm trials, unlike placebo-controlled randomized control trials, forgo the use of a placebo or standard-of-care...
Read article
July 28, 2023
Written by Fei Tang, RWE Senior Research Consultant, and Paul Arora, Assistant Professor (Status), Dalla Lana School of...
Read article
July 14, 2023
Written by Grammati Sarri, David Smalbrugge, Andreas Freitag, and Evie Merinopoulou The vision of a single, centralized...
Read article
May 22, 2023
By Grammati Sarri, Evie Merinopoulou, Vinusha Kalatharan, and Jason Simeone The Canadian Agency for Drugs and...
Read article
May 10, 2023
The evidence is staggering on the unequal health burdens experienced by specific patient groups defined by ethnic,...
Read article
March 21, 2023
One of the lesser-known complications associated with Multiple Sclerosis is a higher risk of serious infections (SIs)....
Read article
March 8, 2023
Real-world data has been increasingly used to answer questions related to the course, prognosis, and treatment of...
Read article
March 7, 2023
Health inequalities are an enduring issue that can be exacerbated by clinical trial recruitment that does not reflect...
Read article
February 14, 2023
The U.S. FDA has recently provided specific guidance[i] on the design and conduct of trials incorporating an external...
Read article
January 31, 2023
Asthma affects more than 235 million people worldwide, and due to lacking effective implementation of clinical...
Read article
October 4, 2022
Integrated Nested Laplacian Approximations (or INLA) are now starting to be used by statisticians as a key tool for...
Read article
May 13, 2021
Cytel’s HEOR and RWE Expertise has grown quite significantly in the past year. Could you speak a little bit about the...
Read article
May 5, 2021
Cytel’s team of HEOR and Real-World Evidence (RWE) experts are all set to make a splash at the Virtual ISPOR on May 17...
Read article
April 21, 2021
Two therapies are placed in head-to-head clinical trials when they are compared against each other as opposed to a...
Read article
April 7, 2021
Scientists at Cytel recently published a paper in the Journal of the American Medical Association (JAMA). Among the...
Read article
April 2, 2021
Earlier this month, my colleagues at Cytel Canada published a paper in JCO Clinical Cancer Informatics, offering a...
Read article
January 22, 2021
COVID-19 has transformed the pharmaceutical industry in a manner that few could have predicted only a year ago. One of...
Read article
December 17, 2020
As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation...
Read article
November 24, 2020
Virtual ISPOR 2020, held November 16 to 19, presented new opportunities for scientific interaction amongst HEOR...
Read article
November 17, 2020
As a part of Cytel’s "New Horizons Webinar Series", Alind Gupta, Senior Data Scientist, presents case studies from his...
Read article
November 12, 2020
Cytel and Ingress Health (now a Cytel company) will be contributing to a range of events at Virtual ISPOR EUROPE 2020,...
Read article
November 5, 2020
In oncology, many manufacturers go into niche indications, where there are very specific tumors, and then they opt for...
Read article
October 22, 2020
In this two-part blog series, we interview Bart Heeg, Vice President HEOR and Founder at Ingress Health (A Cytel...
Read article
October 20, 2020
In this interview with Thomas Wilke, Principal Scientist at Ingress-Health (a Cytel company), we talk to him about his...
Read article
October 19, 2020
COVID-19 has created extreme uncertainties -- a dearth of historical information combined with the need for safety,...
Read article
October 14, 2020
A credible evidence base is needed to support and document the economic value of new technologies and therapeutic...
Read article
September 22, 2020
Research Scientists, Thomas Wilke and Sabrina Mueller recently published a manuscript on “Diabetes-Related...
Read article
August 26, 2020
As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation...
Read article
August 5, 2020
Cytel is conducting two pilot projects on head-to-head comparisons using real world data. These projects in oncology...
Read article
July 23, 2020
Just as there are numerous adaptations that fall within the umbrella of adaptive designs, there are several different...
Read article
April 29, 2020
In our previous blog, we spoke with Alind Gupta, who works as a Machine Learning Researcher at Cytel in Canada. The...
Read article
April 20, 2020
Cytel is hosting a webinar on Transparent Machine Learning in Oncology, on April 21, 2020. Our speaker, Alind Gupta,...
Read article
March 31, 2020
Since 1953, when the discovery of the structure of DNA was made, we have seen great advancements in genomics....
Read article
March 26, 2020
Further regulatory guidance has been released concerning the implications of the Coronavirus disease (COVID-19) on...
Read article
March 23, 2020
On March 20th the European Commission, the European Medicines Agency (EMA) and the Heads of Medicines Agency (HMA)...
Read article
March 19, 2020
The FDA issued a guidance yesterday on how the COVID-19 Pandemic may affect the conduct of clinical trials. Below are...
Read article
June 11, 2015
When the FDA first began to require pharmaceuticals to perform cardiovascular outcome trials to establish the safety of...
Read article
